Technological Advancements in the ADME Toxicology Testing Market
Technological innovation is a key driver in the ADME Toxicology Testing Market. The integration of artificial intelligence and machine learning into in silico modeling has improved the accuracy and speed of toxicity predictions. High-throughput screening methods allow rapid evaluation of thousands of compounds, accelerating drug discovery.
Microfluidics and organs-on-chip platforms provide more physiologically relevant models, reducing dependence on animal testing. These advancements enable more predictive, cost-effective, and ethical toxicity assessments, reshaping the future of ADME testing.
1 View